Target intelligence / Profile preview

Zinc finger protein 254, pseudogene

Molecular classification: Pseudogene, Zinc finger protein family (KRAB-type/C2H2 subtype, inferred from general ZNF pseudogenes[1][3])

Overview

Zinc finger protein 254 pseudogene (ENSG00000257604) is a member of the zinc finger protein family, annotated as a non-functional, processed genomic sequence derived from a duplication event of a zinc finger gene[1]. It does not produce a functional protein product, distinguishing it from transcriptionally active zinc finger proteins, which are heavily involved in DNA binding, transcriptional regulation, and other cellular functions[1][3]. As a pseudogene, ZNF254P is not considered a therapeutic target and has no current or predicted biological or pharmacological roles.

Other names: ZNF254PZinc finger protein 254 pseudogene

Beyond the preview

Go deeper on Zinc finger protein 254, pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 254, pseudogene.

Explore the full profile